USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: ACADEMIC PHARMACEUTICALS, INC.
City: LAKE BLUFF
State: IL
Zip+4: 60044
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $305,106.00 3

Award List:

Digoxin Chiral Isolates as Improved Pharmaceuticals

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: John C. Somberg
Award Amount: $102,008.00
Abstract:
DESCRIPTION (provided by applicant): Digoxin is the first line pharmacologic therapy for CHF and AF. Digoxin increases cardiac contractility and blocks conduction through the AV node slowing the ventricular response to AF and thus slowing the rate of the beating ventricles permitting more time for… More

Pediatric Acceptable Formulation of Amiodarone

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: John C. Somberg
Award Amount: $100,188.00
Abstract:
DESCRIPTION (provided by applicant): IV amiodarone is the first line therapy for life threatening ventricular as well as supraventricular arrhythmias. However, the Tween 80 and benzyl alcohol diluents limits the rate of administration severely, due to hyp otension and myocardial contractile… More

Reducing Methadone's Arrhythmic potential

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: John C. Somberg
Award Amount: $102,910.00
Abstract:
DESCRIPTION (provided by applicant): Methadone is an important long-term maintenance therapy for drug addiction and currently is frequently used for analgesia. However, methadone prolongs the QT interval on the electrocardiogram and this increases risk for life threatening arrhythmias and has led… More